← Back
Data updated: Mar 10, 2026
KVK TECH
Pharmaceuticals
KVK TECH is a generic drug manufacturer with 8 FDA-approved products.
2006
Since
8
Drugs
-
Trials
11
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
HYDROXYZINE HYDROCHLORIDE 2025-12-16
PHENTERMINE HYDROCHLORIDE 2025-07-24
Labeling
PROMETHAZINE HYDROCHLORIDE 2025-06-24
Labeling
HYDROXYZINE HYDROCHLORIDE 2025-04-28
HYDROXYZINE HYDROCHLORIDE 2025-04-22
Labeling
CYCLOBENZAPRINE HYDROCHLORIDE 2024-12-17
Labeling
HYDROXYZINE HYDROCHLORIDE 2024-09-26
Manufacturing (CMC)
CYCLOBENZAPRINE HYDROCHLORIDE 2024-09-12
CYCLOBENZAPRINE HYDROCHLORIDE 2024-08-27
PHENDIMETRAZINE TARTRATE 2024-08-02
Manufacturing (CMC)
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (7)
Company Info
- First Approval
- 2006-07-31
- Latest
- 2021-01-05
- Applications
- 13
FDA Sponsor Names
KVK TECHKVK TECH INC